.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Teva
Chinese Patent Office
Express Scripts
Baxter
Mallinckrodt
Daiichi Sankyo
Healthtrust
Federal Trade Commission
Cerilliant

Generated: September 22, 2017

DrugPatentWatch Database Preview

GEMONIL Drug Profile

« Back to Dashboard

What is the patent landscape for Gemonil, and what generic Gemonil alternatives are available?

Gemonil is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in GEMONIL is metharbital. Additional details are available on the metharbital profile page.

Summary for Tradename: GEMONIL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list18
Patent Applications: see list1,014
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GEMONIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
GEMONIL
metharbital
TABLET;ORAL008322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
UBS
Moodys
US Army
Citi
Baxter
McKinsey
Covington
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot